Heeyoung Park Email

VP, Regulatory . Graviton Bioscience

Current Roles

Employees:
49
Revenue:
$7.6M
About
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.
Graviton Bioscience Address

New York, NY
United States
Graviton Bioscience Email

Past Companies

Graviton Bioscience CorporationVice President, Regulatory
Aptinyx Inc.Head and Senior Director, Regulatory and Quality
LEO PharmaDirector, Regulatory Affairs